Canopy Growth Corporation - Common Shares (CGC)
1.9797
-0.1203 (-5.73%)
Canopy Growth Corp is a leading player in the cannabis industry, focusing on the production and distribution of a wide range of cannabis products
The company is engaged in cultivating and processing cannabis for both medical and recreational purposes, offering various forms such as dried flower, oils, edibles, and beverages. With a commitment to innovation, Canopy Growth invests in research and development to create high-quality products that meet consumer demands and adhere to evolving regulations. The company also emphasizes sustainability and responsible business practices, aiming to shape the future of cannabis consumption and enhance the overall experience for consumers.
Biden Commutes the Sentences of Almost 2,500 Inmates Convicted on Drug Offences
Former U.S. President Joe Biden commuted the sentences of almost 2,500 inmates convicted of various non-violent drug offenses ( including marijuana ) during his last days in the Oval Office. Biden noted that with this last round of commutations, he has granted clemency to more Americans than any other president in U.S. history.
Via CannabisNewsWire · January 23, 2025
420 with CNW — Marijuana Industry Predictions for 2025
The marijuana industry experienced a sluggish pace of progress in 2024. Efforts to pass cannabis reform measures in Congress fell short, and the DEA delayed rescheduling cannabis as a recognized medicinal substance.
Via CannabisNewsWire · January 13, 2025
Recent Scientific Findings Altering Our Knowledge about Marijuana
While around one in every five Americans now use marijuana, the understanding of its health effects has historically been limited . However, as regulations surrounding cannabis ease, scientists are gaining new insights into its benefits and risks.
Via CannabisNewsWire · December 26, 2024
Marijuana Users Spend Fewer Days in Hospital for Epilepsy, Study Finds
A new study has found that marijuana users with epilepsy typically spend fewer days in the hospital for epilepsy-related issues compared to people with epilepsy who didn’t use cannabis. Data from the study shows that epileptic individuals who used cannabis had an elevated epilepsy event capturability rate and reduced hospital stays.
Via CannabisNewsWire · December 13, 2024
420 with CNW — Federal Court Upholds Ban on Cannabis Advertising in Mississippi
Mississippi’s medical cannabis businesses are prohibited from advertising on billboards or any other platforms due to marijuana’s federal status as an illegal substance, according to a recent decision by an appeals court.
Via CannabisNewsWire · December 5, 2024
Maryland Starts Using Dashboard for Tracking Marijuana Use
The Department of Health in the state of Maryland recently rolled out a tool to track the effects of marijuana use on public health. The tool, dubbed the Cannabis Public Health Data Dashboard, offers user-friendly visualizations of marijuana trends prior to and after the legalization of recreational marijuana.
Via CannabisNewsWire · November 22, 2024
New Research Finds Marijuana Use Lowers Opioid and Alcohol Consumption
New research suggests that the use of marijuana may lower the use of alcohol, opioids and methamphetamine. The research focused on the effect of marijuana consumption on individuals’ use of other drugs.
Via CannabisNewsWire · November 12, 2024
Multistate Operators and Their Contribution to the Marijuana Industry
The rise of marijuana multistate operators has increased concerns that independent cannabis business owners may be driven out of business by organizations that have more money, power, and influence.
Via CannabisNewsWire · November 1, 2024
420 with CNW — NIH Says Oncologists Aren’t Equipped to Answer Cancer Patients’ Questions on Medical Marijuana
Recent research highlights the increasing use of marijuana among individuals undergoing cancer treatment and the associated implications of this trend. Various studies indicate that approximately 20%-40% of cancer patients turn to cannabinoids or medical marijuana to alleviate side effects such as stress, anxiety, insomnia, pain, and nausea.
Via CannabisNewsWire · October 25, 2024
420 with CNW — Research Says Most Americans Distrust Government as Cannabis Information Source
According to a recent study, many American adults tend to obtain information about cannabis not from government or medical resources but rather from friends and family. The study, which included a nationally representative sample of 1,161 participants, highlighted that government websites were the least preferred source for marijuana-related information, accounting for just 4.7% of respondents. Health providers were slightly more popular, with 9.3% citing them as a source. Interestingly, budtenders who provide guidance in cannabis dispensaries were at 8.6%.
Via CannabisNewsWire · October 17, 2024
InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC), Canopy Growth Corp. Ink Australian Distribution Deal for Storz & Bickel Vaporizers
Flora Growth (NASDAQFLGC), a consumer-packaged goods leader and pharmaceutical distributor, is partnering with Canopy Growth Corp. NASDAQ: CGCNASDAQCGC)
Via Investor Brand Network · October 14, 2024
Kentucky Issues First Medical Cannabis Business License
Last week, the state of Kentucky awarded the first license for its medical marijuana program to KCA Labs . The state legalized medical marijuana in March 2023, following the signing of SB 47 into law by Governor Andy Beshear. SB 47 legalized the use of medical marijuana for individuals suffering from various debilitating diseases, including multiple sclerosis, cancer, epilepsy, post-traumatic stress disorder, chronic nausea and chronic pain.
Via CannabisNewsWire · October 4, 2024
Fueled by evolving regulations and strong market growth, the cannabis sector has emerged as a potentially lucrative long-term investment opportunity.
Via MarketBeat · October 2, 2024
420 with CNW — Study Shows Users of Medical Cannabis Report Short-Term Benefits in Quality of Life
A recent study involving hundreds of individuals using medical cannabis has shown significant and rapid improvements in overall health during the first three months of use, according to research from the Philadelphia College of Osteopathic Medicine (PCOM). The findings, published in the “Cannabis Research Journal,” followed almost 400 adults in Pennsylvania who were new to medical marijuana treatments.
Via CannabisNewsWire · September 25, 2024
420 with CNW — Study Finds Drop in Marijuana Use by Teens, Rise Among Adults
A recent study revealed that marijuana use has been on the rise in the United States, though surprisingly not among young teens. The study, which analyzed the cannabis consumption habits of more than 500,000 people between 2013 and 2022, was published in the latest edition of Drug and Alcohol Dependence Reports. It highlighted that marijuana use saw significant growth among individuals living in households with an annual income exceeding $75,000 and those holding college degrees.
Via CannabisNewsWire · September 16, 2024
420 with CNW — Mothers in Brazil Take Lead in Advocating for Medical Cannabis for Sick Children
Brazil’s most populated state, Sao Paulo, home to more than 44 million residents, made history by being the first to pass legislation granting free access to CBD . The legislative victory was largely driven by Brazilian mothers who spent a decade campaigning tirelessly to access CBD for their ill children.
Via CannabisNewsWire · September 5, 2024
420 with CNW — Ohio’s Adult-Use Cannabis Sales Exceed $11M in First Week
Ohio’s recreational marijuana market has experienced impressive growth, generating more than $11.5 million in sales in its first week. According to the state’s Commerce Department, Cannabis Control Division, the total revenue from adult-use cannabis sales reached $11,530,708 as of Aug. 10, 2024.
Via CannabisNewsWire · August 27, 2024
The melt-up continued this week after benign inflation readings and a surprise jump in retail sales calmed recession fears and elevated hopes for a rate cut
Via MarketBeat · August 17, 2024
Canopy Growth is improving its margins and inching closer to profitability. However, proposed changes to the treatment of cannabis in the U.S. won't help much.
Via MarketBeat · August 14, 2024
Australian Farmers Look to Tap Continental Opportunities as Cannabis Laws Ease
The marijuana business in Australia is booming, with farms in the country expanding to capitalize on growing demand. Estimates show that global legal marijuana spending may hit $153 billion by 2027. This is quite an increase, especially when compared to the $56 billion spent in 2022.
Via CannabisNewsWire · August 12, 2024
Canopy Growth and Aurora Cannabis demonstrate contrasting strategies in the cannabis sector, each seeking profitability in a challenging market.
Via MarketBeat · August 9, 2024
420 with CNW — CU Anschutz Researchers Studying Users’ Capacity to Drive Under Influence of Marijuana
Researchers at the CU Anschutz School of Public Health have embarked on a paid study focusing on marijuana users to examine impairment levels . Over the past two years, the research has involved more than 200 participants aged between 25 and 55 years. Depending on the amount of marijuana consumed, each study session can last anywhere from three to five hours.
Via CannabisNewsWire · August 6, 2024
Thai Marijuana Advocates Protest Plans to Outlaw Substance Again
In June 2022, Thailand made the decision to decriminalize marijuana, making it the first country in southeast Asia to do so. The campaign to decriminalize the drug was spearheaded by Anutin Charnvirakul of the Bhumjaithai Party.
Via CannabisNewsWire · July 12, 2024
By Financial Buzz Media · Via GlobeNewswire · July 11, 2024
420 with CNW — Brazilian Supreme Court Ends Criminalization of Cannabis Possession for Personal Use
The Brazilian Supreme Court recently voted to decriminalize cannabis possession for personal use, joining other Latin American nations in this reform and potentially reducing its substantial prison population. The majority of the justices, since the discussions began in 2015, have supported this move.
Via CannabisNewsWire · July 8, 2024